RAPT Therapeutics, Inc. (RAPT)
$58.01+0.00%Close
BUYBULL · day 28
Key stats
- Market cap
- $959M
- Beta
- 0.44
- P/E (TTM)
- -44.46
- 1W
- +0.05%
- 1M
- +0.40%
- vs SPY 1W
- +0.19%
- vs SPY 1M
- -2.11%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
Loading headlines…
FAQ
- What is LOPJLB’s current signal on RAPT?
- LOPJLB’s latest quantitative signal on RAPT Therapeutics, Inc. (RAPT) is BUY in a BULL regime. Signals are updated daily.
- What market regime is RAPT in?
- RAPT Therapeutics, Inc. (RAPT) is currently classified in the BULL HMM market regime on LOPJLB.
- What does RAPT Therapeutics, Inc. (RAPT) do?
- RAPT Therapeutics, Inc. is a clinical-stage biopharmaceutical firm specializing in immunology. The company is dedicated to discovering, developing, and commercializing innovative oral small molecule therapies. These treatments are aimed at addressing critical unmet medical needs for patients battling oncology and inflammatory diseases. Its primary drug candidate for inflammation, RPT193, functi…